At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,224 enrolled
Drug / intervention
Antiretroviral Regimensdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Quality of Life and Healthcare Utilization Substudy
National Institute of Allergy and Infectious Diseases (NIAID)·observational·Posted Oct 11, 2006·Updated Apr 21, 2014
In Brief
An observational study evaluating Antiretroviral Regimens for HIV Infections. Completed, enrolled 1,224 participants across 67 sites.
Detailed Summary
The purpose of this study is to compare the effects of two different anti-HIV drug regimens on quality of life and health care utilization among SMART study participants.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Infections
CountriesUnited States
CollaboratorsCommunity Programs for Clinical Research on AIDS
Timeline
N/ACompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2002
First PostedOct 2006
Primary CompletionNov 2008
TodayJul 2026
First PostedOct 11, 2006
Enrollment StartJan 1, 2002
Primary CompletionNov 1, 2008
TodayJul 2, 2026
Enrollment to primary: 6.8 yearsPosted 19.7 years ago
Interventions
Antiretroviral Regimensdrug
Various antiretroviral therapy combinations already being administered to participants